CDA
Cytidine deaminase
Also known as: CDD, CDD_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P32320
- Gene
- CDA
- Ensembl
- ENSG00000158825
- Chromosome
- 1
- Canonical length
- 146 aa
- Protein class
- Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
This gene encodes an enzyme involved in pyrimidine salvaging. The encoded protein forms a homotetramer that catalyzes the irreversible hydrolytic deamination of cytidine and deoxycytidine to uridine and deoxyuridine, respectively. It is one of several deaminases responsible for maintaining the cellular pyrimidine pool. Mutations in this gene are associated with decreased sensitivity to the cytosine nucleoside analogue cytosine arabinoside used in the treatment of certain childhood leukemias. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
146 residues, UniProt reviewed canonical sequence.
>P32320|CDA
1 MAQKRPACTL KPECVQQLLV CSQEAKKSAY CPYSHFPVGA ALLTQEGRIF KGCNIENACY
61 PLGICAERTA IQKAVSEGYK DFRAIAIASD MQDDFISPCG ACRQVMREFG TNWPVYMTKP
121 DGTYIVMTVQ ELLPSSFGPE DLQKTQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 183 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 183 nTPM
- esophagus: 108 nTPM
- liver: 81 nTPM
- vagina: 47 nTPM
- cervix: 45 nTPM
- spleen: 29 nTPM
Single-cell type
- esophageal apical cells: 1,689 nCPM
- neutrophils: 883 nCPM
- neutrophil progenitors: 636 nCPM
- esophageal suprabasal cells: 458 nCPM
- colonocytes: 322 nCPM
- hepatocytes: 182 nCPM
Immune cell
- neutrophil: 1,240 nTPM
- eosinophil: 472 nTPM
- basophil: 218 nTPM
- classical monocyte: 208 nTPM
- intermediate monocyte: 125 nTPM
- non-classical monocyte: 112 nTPM
Brain region
- pons: 5.7 nTPM
- thalamus: 4.7 nTPM
- cerebral cortex: 4.4 nTPM
- medulla oblongata: 4.3 nTPM
- white matter: 4 nTPM
- hypothalamus: 3.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.32
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.3
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to external biotic stimulus
- CMP catabolic process
- cytosine metabolic process
- dCMP catabolic process
- UMP salvage
- pyrimidine-containing compound salvage
Molecular functions
- cytidine deaminase activity
- identical protein binding
- nucleoside binding
- protein homodimerization activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cytidine and deoxycytidylate deaminase domain
- APOBEC/CMP deaminase, zinc-binding
- Cytidine deaminase-like
- Cytidine and deoxycytidylate deaminase zinc-binding region
- Cytidine deaminase, homotetrameric
- Cytidine and Deoxycytidylate Deaminase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDA as an antibody target. Whether an autoantibody or antibody against CDA could matter depends on whether native CDA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDA is annotated as secreted, so native CDA circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label CDA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...